Recent News

• 06.16.2025 - June 16, 2025 - June 19, 2025 : 2025 BIO International Convention
• 05.11.2025 - Entera Bio Announces First Quarter 2025 Financial Results and Business Updates
• 05.11.2025 - Entera Bio’s EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis – Highlighted as Oral Presentation at WCO-IOF ESCEO
• 05.09.2025 - Entera Bio Announces First Quarter 2025 Financial Results and Business Updates
• 05.09.2025 - Entera Bio Announces First Quarter 2025 Financial Results and Business Updates
• 04.15.2025 - Entera Bio’s EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO
• 04.15.2025 - Entera Bio’s EB613 Demonstrates Early Impact on Both Trabecular and Cortical Bone Compartments with 6 Months of Treatment in Post-Menopausal Women with Osteoporosis - Highlighted as Oral Presentation at WCO-IOF ESCEO
• 04.11.2025 - 2025 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO)
• 04.11.2025 - April 11, 2025 - April 13, 2025 : 2025 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO)
• 04.10.2025 - April 10, 2025 - April 13, 2025 : 2025 World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO)

Recent Filings

• 05.09.2025 - 8-K Current report
• 05.09.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.09.2025 - EX-99.1 EX-99.1
• 04.30.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.03.2025 - 4 Statement of changes in beneficial ownership of securities
• 04.02.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors
• 03.28.2025 - EX-99.1 EX-99.1
• 03.28.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]